FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1075411000202109: Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
11779611000202111 Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
11794301000202111 Empagliflozin 25 mg and linagliptin 5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
11779611000202111 Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
11794301000202111 Empagliflozin 25 mg and linagliptin 5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing only empagliflozin and linagliptin in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Linagliptin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Linagliptin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Empagliflozin true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Empagliflozin true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start